|
JPH11258235A
|
|
Method for detecting and identifying parathyroid hypertensive factor
|
|
US5886012A
|
|
Method of treatment for disease associated with excessive PHF using combination therapy involving exogenous calcium and calcium channel blockers
|
|
US5350771A
|
|
Method and treatment for hypertension using combination therapy involving exogenous calcium and calcium channel blockers
|
|
WO9306846A1
|
|
Parathyroid hormone analogues and use in osteoporosis treatment
|
|
US5317010A
|
|
Parathyroid hormone analogues substituted at AA 25, 26, 27, and use in osteoporosis treatment
|
|
US5192664A
|
|
Parathyroid hypertensive factor, antibodies and uses thereof
|
|
CA2030516A1
|
|
Parathyroid hypertensive factor
|
|
KR0159990B1
|
|
Pharmaceutical compositions for the treatment of hypertension
|
|
CA2288407A1
|
|
Parathyroid hypertensive factor
|
|
HU903677D0
|
|
Process for producing hypertonic factor of the parathyroid, diagnostical process for detacting the factor and diagnostical kit for them
|
|
US4966893A
|
|
Method for treatment of senile dementia
|
